Cargando…

Pancreatic safety of DPP-4 inhibitors in type 2 diabetes millitus: A protocol for systematic review and network meta-analysis

BACKGROUND: Dipeptidyl-peptidase IV inhibitor (DPP-4i) is a common hypoglycemic medication in treating type 2 diabetes millitus. It has become widely utilized in clinical practice due to its ability to effectively manage blood glucose while posing a low risk of hypoglycemia and weight gain. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, Dong, Youzi, Li, Baohua, Ning, Bobiao, Zhao, Quanlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276269/ https://www.ncbi.nlm.nih.gov/pubmed/35512071 http://dx.doi.org/10.1097/MD.0000000000029154

Ejemplares similares

Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study
por: Chin, Hyouk-Jun, et al.
Publicado: (2017)

Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
por: Park, Se Hee, et al.
Publicado: (2016)

The efficacy and safety of acupoint injection for diabetic gastroparesis: A protocol for systematic review and meta-analysis
por: Long, Tao, et al.
Publicado: (2020)

Efficacy and safety of metformin in the treatment of gestational diabetes: A protocol for systematic review and meta-analysis
por: Mao, Weirong, et al.
Publicado: (2021)

Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis
por: An, Wenrong, et al.
Publicado: (2021)

Effect of dipeptidyl peptidase-4 inhibitors inhibitor on cognitive dysfunction in diabetes: A protocol for systematic review and meta analysis
por: Liu, Shiyu, et al.
Publicado: (2020)

Adiposity and Other Etiological Factors in Diabetes Millitus
Publicado: (1926)

Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
por: Wang, Shengju, et al.
Publicado: (2020)

Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes: Protocol for a systematic review and meta-analysis
por: Shi, Fang-Hong, et al.
Publicado: (2018)

Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2019)

The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Gao, Qian, et al.
Publicado: (2021)

Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials
por: Yang, Yingying, et al.
Publicado: (2017)

The safety and feasibility of comprehensive nutrition care in pregnant women with gestational diabetes mellitus: A protocol for systematic review and meta-analysis
por: Long, Mei, et al.
Publicado: (2021)

Clinical efficacy and safety of Chinese herbal medicine for the treatment of patients with early diabetic nephropathy: A protocol for systematic review and meta-analysis
por: Yang, Xiaomei, et al.
Publicado: (2020)

Efficacy and safety of traditional Chinese medicine injection with mecobalamin in treating diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis
por: Mai, Weihua, et al.
Publicado: (2021)

The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis
por: Guan, Hailian, et al.
Publicado: (2020)

The effect of psychotherapy on anxiety, depression, and quality of life in patients with diabetic retinopathy: A protocol for systematic review and network meta-analysis
por: Li, Suiping, et al.
Publicado: (2021)

Efficacy and safety of pasireotide for Cushing's disease: A protocol for systematic review and meta-analysis
por: Zhao, Nairui, et al.
Publicado: (2020)

Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis
por: Liang, Hui-ling, et al.
Publicado: (2017)

Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis
por: Chen, Han, et al.
Publicado: (2023)

The effectiveness and safety of recombinant human growth hormone combined with alginate dressing in the treatment of diabetic foot ulcer: A protocol for systematic review and meta-analysis
por: Zhou, Deng-Rong, et al.
Publicado: (2021)

Tuina for diabetes with obesity: Protocol for a systematic review and meta-analysis
por: Peng, Sihan, et al.
Publicado: (2021)

Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus: A meta-analysis
por: Li, Jian, et al.
Publicado: (2017)

The efficacy and safety of combined methotrexate with anti-vascular endothelial growth factor therapy in treatment of diabetic macular edema: A protocol for systematic review and meta-analysis
por: Bao, Yuzhi, et al.
Publicado: (2021)

Effect of SGLT inhibitors on weight and lipid metabolism at 24 weeks of treatment in patients with diabetes mellitus: A systematic review and network meta-analysis
por: Chen, Mao-bing, et al.
Publicado: (2021)

The efficacy of sodium glucose co-transport-2 inhibitors on glycemic control for patients with type 1 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Zhang, Yajie, et al.
Publicado: (2021)

Acupuncture and related therapies for hyperlipidemia: A protocol for systematic review and network meta-analysis
por: Wang, Xue-Song, et al.
Publicado: (2020)

Effects of different dosages of Sodium-Glucose Transporter 2 Inhibitors on lipid levels in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Cai, Tingyu, et al.
Publicado: (2020)

The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Yang, Yan, et al.
Publicado: (2020)

A randomized controlled trial protocol of the cardiovascular safety and efficacy of liraglutide in the treatment of type 2 diabetes
por: Liang, Ying, et al.
Publicado: (2021)

The effect of diabetes on mortality of COVID-19: A protocol for systematic review and meta-analysis
por: Yang, Yan, et al.
Publicado: (2020)

Acupoint injection therapy for diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Zhou, Yanni, et al.
Publicado: (2021)

Suoquan pill for the treatment of diabetic nephropathy: A protocol for systematic review and meta-analysis
por: Cai, Piao, et al.
Publicado: (2021)

The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A meta-analysis
por: Gao, Qian, et al.
Publicado: (2021)

Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis
por: Yang, Wenxiao, et al.
Publicado: (2021)

Impact of demographic characteristics and antihyperglycemic and cardiovascular drugs on the cardiorenal benefits of SGLT2 inhibitors in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Chang, Rong, et al.
Publicado: (2021)

Qizhijiangtang capsule for the treatment of diabetic kidney disease: A protocol for systematic review and meta-analysis
por: Tan, Yumeng, et al.
Publicado: (2020)

The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis
por: Yao, Jia, et al.
Publicado: (2020)

Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis
por: Shi, Xiao-yan, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes in Taiwan: A Population-Based Cohort Study
por: Lai, Yun-Ju, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0hsfg4lia9169dl1klkir7qcff